Summary. Cerebral blood flow and metabolism were measured by the iodoantipyrine-4-131I method in nine patients and by the nitrous oxide method in three patients with the Wernicke-Korsakoff syndrome.
Introduction
The syndrome first described in 1881 by Carl Wernicke (1) and presently considered to be characterized by disturbances in ocular motility, dementia, severe dysfunction of retentive memory, ataxia, and peripheral neuritis has been the object of many clinical and neuropathological studies (2) (3) (4) (5) (6) (7) . It is most frequently observed in severe chronic alcoholics and is thought to be the consequence of nutritional deficiency. The mental abnormalities may be permanent despite improvement of the other clinical manifestations after adequate dietary therapy (8) (9) (10) . This study was undertaken to measure the cerebral circulatory and metabolic defects that occur in this syndrome as a means of further identifying its basic pathophysiology.
Methods
Cerebral blood flow (CBF) was measured by the iodoantipyrine-4-'I method (IAP) (11) ten times in nine patients and by the nitrous oxide method of Kety and Schmidt (12) four times in three patients. The diagnosis was a clinical one and depended upon the criteria now accepted as characteristic of Wernicke-Korsakoff syndrome (13) . All (15) (16) (17) .
Blood glucose was determined by the enzymatic method described by Washko and (11) .
Results The cerebral circulatory and metabolic functions are summarized in Table I . The controls for the antipyrine-l31I studies were in a comparable age range (11) , and the controls from the nitrous oxide studies were obtained from five hospitalized patients in a similar age group without demonstrable cerebral disease. The IAP cerebral blood flows varied from 554 to 829 ml per minute, with a mean of 652 ml per minute. This represents a reduction of 34% from the creased CVR may be found in the observation that the mean arterial-cerebral venous oxygen and glucose differences were normal. A reduction of CBF in the presence of normal brain metabolism is accompanied by widened arterialcerebral venous oxygen and glucose differences (19) (20) (21) (22) , and those instances in which cerebral metabolic rate is reduced as a consequence of primary reduction in blood flow manifest increased oxygen and glucose extraction (20, 23, 24) . Although the normal values for oxygen and glucose extraction in these patients in the face of profoundly reduced CMR02 and CMRg1 do not prove that the reduction of brain metabolism is the primary event, the reasoning from the analogy of the above cited examples would suggest that this is so. In this event the elevated vascular resistance is another example of the well-known and remarkable property of the cerebral vasculature to regulate itself to meet the lessened demand of the tissues for blood. This is consistent with what is known to occur in other metabolic and toxic encephalopathies such as myxedema, methyl alcohol poisoning, general anesthesia, pernicious anemia, and insulin hypoglycemia (25) (26) (27) (28) (29) (30) . Although mean jugular venous Po2 was normal in this study, in four instances a striking reduction from normal of CBF and CMRo2 was associated with jugular Po2 values well above the usual normal range, further suggesting the inability of the cerebral cells to extract oxygen normally.
An alternative explanation for the reduced brain metabolism in these patients is that CBF is reduced as a consequence of occlusive cerebral vascular disease or a "vasculitis" in the Wernicke-Korsakoff syndrome. Although this hypothesis cannot be excluded absolutely on the basis of these data, it seems unlikely. There is no pathological confirmation of such a phenomenon. In addition, as has been cited above, cerebral hemodynamic studies in occlusive cerebral vascular disease due to hypertension or atherosclerosis or both demonstrate that there is increased oxygen extraction as CBF decreases.
The pattern of relationship of normal arterialcerebral venous oxygen differences with depressed CMRo2 is consonant with the clinical evidence suggesting the Wernicke-Korsakoff syndrome to be a cerebral metabolic disorder sometimes of striking reversibility. The results do not differentiate between a toxic and a nutritional cause for the metabolic disorder, but clinical and pathological evidence clearly shows that it is the latter. The striking pathological lesions in these patients attest to the morphological disturbance that can occur as a consequence of a nutritional defect. A similar relationship exists in pernicious anemia (vitamin B12 deficiency), although the cerebral pathologic lesion in this disorder is not so distinctive as the spinal lesion. If the site of the pathology is a clue to the anatomical localization of the metabolic defect in the Wernicke-Korsakoff syndome, one must conclude that thiamine deficiency has a specific effect on the metabolism of cells in the periaqueductal and periventricular gray matter, the mammillary bodies, the dorsomedial nuclei of the thalamus, the hypothalamus, the cerebellum, the hippocampi, and the fornices (3, 7) , sparing large areas of the brain, specifically the cerebral cortex, which lacks characteristic lesions. These data further clearly demonstrate that fairly localized metabolic defects may result in striking reduction of total cerebral blood flow and metabolism. This degree of reduction in brain metabolism is usually thought to be accompanied by altered states of awareness of significant degree (general anesthesia, hypoglycemic coma, hepatic encephalopathy, elevated blood alcohol, and so forth), but our evidence shows convincingly that this relationship is not constant, and that disturbance of consciousness is a function of the location of the lesion, not the degree of metabolic defect, for drowsiness was not a characteristic of the clinical state of these patients. The data on the two patients who were restudied after an additional 2 to 3 weeks of treatment (A. M. and K. C.) confirm the clinical observation that recovery in this illness is usually incomplete. It is well known that the mental disorders, particularly the disturbance of retentive memory, may persist for months and even indefinitely. As a matter of fact, some degree of residual abnormality is the rule. In these two patients there was no improvement in brain blood flow or metabolism.
The normal cerebral respiratory quotient in these patients was somewhat surprising, since it might be -theorized that the co-carboxylase defect of thiamine deficiency with its resultant alteration of aerobic glucose metabolism might significantly reduce RQ, perhaps by resultant metabolism of cerebral lipids. If this occurs, it was not reflected in our study, perhaps because of the thiamine treatment that all these patients had received in the interval between the time-of hospital admission and the study.
We cannot explain the lack of correlation between CBF or CMRo2 and clinical severity according to the arbitrary system described above; probably this is a reflection of the inadequacy of such a clinical grading scheme.
The occurrence of diffuse electroencephalographic abnormalities of a nonspecific nature in only three of these patients, none of whom had altered consciousness, strongly indicates that EEG abnormalities do not necessarily occur in altered cerebral metabolic states.
